Eric D Shah Selected Research

Eric D Shah Research Topics

11	Constipation 10/2023 - 01/2018
10	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2023 - 01/2018
9	Diarrhea 01/2023 - 01/2018
6	Neoplasms (Cancer) 01/2024 - 05/2014
3	Hemorrhage 01/2024 - 01/2019
2	Esophageal Achalasia (Megaesophagus) 12/2023 - 01/2019
2	Abdominal Pain (Pain, Abdominal) 01/2023 - 10/2022
2	Opioid-Induced Constipation 01/2023 - 01/2023
2	Infections 01/2021 - 01/2017
2	Polyps 01/2020 - 01/2020
1	Esophagitis 02/2024
1	Heartburn (Pyrosis) 02/2024
1	Gastroesophageal Reflux (GERD) 02/2024
1	Rectal Diseases (Rectal Disease) 10/2023
1	Rheumatoid Arthritis 10/2023
1	Fecal Incontinence 10/2023
1	Heart Failure 10/2023
1	Ataxia (Dyssynergia) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Mood Disorders (Mood Disorder) 01/2022
1	Pain (Aches) 01/2022
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Diabetes Mellitus 01/2021
1	Pathologic Constriction (Stenosis) 01/2020
1	Fistula 01/2020
1	Esophageal Diseases 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Ulcerative Colitis 04/2016
1	Crohn Disease (Crohn's Disease) 08/2015

5	Prescription DrugsIBA 10/2023 - 01/2021
4	LaxativesIBA 10/2023 - 01/2023
4	Rifaximin (L 105)FDA Link 01/2023 - 12/2019
4	linaclotideIBA 01/2022 - 01/2018
3	Lubiprostone FDA Link 01/2022 - 01/2020
3	Immunologic Factors (Immunomodulators)IBA 01/2021 - 08/2015
2	methylnaltrexone FDA Link 01/2023 - 01/2023
2	eluxadolineIBA 01/2022 - 11/2021
2	plecanatideIBA 11/2021 - 01/2018
2	tegaserod (Zelnorm)FDA Link 11/2021 - 01/2021
1	Proton Pump InhibitorsIBA 02/2024
1	PowdersIBA 01/2024
1	Hemostatics (Antihemorrhagics)IBA 01/2024
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2023
1	HydrogenIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	N 30IBA 01/2023
1	SecretagoguesIBA 01/2022
1	ZincIBA 01/2022
1	Narcotics (Narcotic Analgesics)IBA 01/2022
1	BenzodiazepinesIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	tenapanorIBA 11/2021
1	alosetron (Lotronex)FDA Link 11/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	CytokinesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	MetalsIBA 01/2020
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2018
1	Guanylyl Cyclase C AgonistsIBA 01/2018
1	golimumab FDA Link 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	IntegrinsIBA 01/2017
1	Infliximab (Remicade)FDA Link 01/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	Investigational DrugsIBA 05/2014

14	Therapeutics 02/2024 - 08/2015
4	Physical Therapy Modalities (Physical Therapy Technique) 10/2023 - 01/2023
2	Myotomy 12/2023 - 01/2019
2	Surgical Instruments (Clip) 01/2020 - 01/2020
2	Biological Therapy 01/2020 - 08/2015
1	Patient Readmission 01/2024
1	Hemostatic Techniques 01/2024
1	Psychology Biofeedback (Biofeedback) 10/2023
1	Polypharmacy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Sutures (Suture) 01/2020
1	Stents 01/2020
1	Laparotomy 01/2019
1	Fundoplication 01/2019
1	Heller Myotomy 01/2019